Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence
Shashi Kiran Misra, Kamla Pathak
Colloids and Interfaces (2023) Vol. 7, Iss. 1, pp. 23-23
Open Access | Times Cited: 23

Showing 23 citing articles:

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 20
Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers
Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38191-38203
Open Access | Times Cited: 25
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
Naeem Mubarak, Muhammad Ahsan Waqar, Asad Majeed Khan, et al.
Designed Monomers & Polymers (2025) Vol. 28, Iss. 1, pp. 7-29
Open Access | Times Cited: 1
Mitochondrial signaling pathways and their role in cancer drug resistance
Ashwani Sharma, Tarun Virmani, Girish Kumar, et al.
Cellular Signalling (2024) Vol. 122, pp. 111329-111329
Closed Access | Times Cited: 8
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
Aline de Alcântara Correia, João Nuno Moreira, José Manuel Sousa Lobo, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1731-1748
Closed Access | Times Cited: 14
Brain targeting of zolmitriptan via transdermal terpesomes: statistical optimization and in vivo biodistribution study by 99mTc radiolabeling technique
Mai Ahmed Tawfik, Mai M. Eltaweel, Ahmed M. Fatouh, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 12, pp. 3059-3076
Open Access | Times Cited: 13
Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
Gulshan Sharma, Karan Wadhwa, Shobhit Kumar, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes
Maria D. Chatzidaki, Evgenia Mitsou
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 337-337
Open Access
Intranasal Drug Delivery: Pathways, Challenges, and Advancements in CNS Targeting
Noura Al‐Hajaj, Reem Khalil, Ghaleb A. Husseini
Journal of Drug Delivery Science and Technology (2025), pp. 106825-106825
Closed Access
Lipid nanoparticles for treatment of glioblastoma multiforme: current status of research and clinical translation
Mugdha Kulkarni, Karthik Nadendla, Ananth Pai, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106891-106891
Open Access
β-Cyclodextrin-functionalized nanocarriers for bromocriptine: development, evaluation and histopathological studies
Muhammad Ahsan Waqar, Iqra Khan, Shabab Zahra, et al.
Journal of Microencapsulation (2025), pp. 1-15
Closed Access
Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
Shivam Singh, Kunal Khurana, Shikha Baghel Chauhan, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Nanoparticulate drug delivery systems for colonic disorders
Girish Kumar, Tarun Virmani, Ashwani Sharma, et al.
Elsevier eBooks (2024), pp. 317-344
Closed Access | Times Cited: 2
Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders
Clara Grosso, Aurora Silva, Cristina Delerue‐Matos, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1721-1721
Open Access | Times Cited: 5
An overview on recent approaches for colonic drug delivery systems
Aylin Deljavan Ghodrati, Tansel Çomoğlu
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 566-581
Closed Access | Times Cited: 1
QUALITY BY DESIGN ENABLES FORMULATION DEVELOPMENT OF ZOLMITRIPTAN LOADED ETHOSOMAL INTRA-NASAL GEL FOR BRAIN TARGETING: IN VITRO AND EX VIVO EVALUATION
Nagadivya Nerella, Vasudha Bakshi
International Journal of Applied Pharmaceutics (2024), pp. 142-153
Open Access | Times Cited: 1
Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders
R. K. Upadhyay, Priyanka Ghosh, Madhuri Desavathu
International Journal of Pharmaceutics (2024), pp. 124866-124866
Closed Access | Times Cited: 1
Magnetic Nanoemulsions for the Intra-Articular Delivery of Ascorbic Acid and Dexamethasone
Camelia-Mihaela Zară-Dănceanu, Cristina Stavilă, Anca Emanuela Minuti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11916-11916
Open Access | Times Cited: 2
A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus
Devika Unnithan, Ali Sartaj, Mohammad Kashif Iqubal, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 437-456
Closed Access
An “All‐in‐One” Strategy to Reconstruct Temporomandibular Joint Osteoarthritic Microenvironment Using γ‐Fe2O3@TA@ALN Nanoparticles
Xiao Cen, Junjie Deng, Xuefeng Pan, et al.
Small (2024)
Closed Access
A Review on Nose to Brain Drug Delivery Using Nanoparticles
Mrunal K. Shirsat, Snehal Kadbhane, Vilas Rane, et al.
International Journal of Advanced Research in Science Communication and Technology (2024), pp. 180-185
Open Access
Intranasal route for brain targeting of Naringenin- a potential antioxidant drug for the treatment of Parkinson’s disease using nano-emulsion as the drug delivery carrier
Shatakshi Lall
(2020)
Open Access | Times Cited: 1
Page 1

Scroll to top